Discover the target selection, drug design and preclinical strategies to identify differentiated targets, optimize next-generation radiopharmaceuticals and build the evidence needed to progress towards the clinic.
Position your expertise in front of 100+ discovery and preclinical RLT leaders actively seeking technologies, services and specialist partners across target discovery, drug design, imaging, radiochemistry, preclinical development, dosimetry, and safety.
Join 100+ radiochemists, biologists, drug designers, and R&D leaders advancing next-generation radioligand therapies from discovery through translation.